Morgan Stanley’s Picard Medical PMI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$271 Sell
33
-95
-74% -$2.02K ﹤0.01% 7800
2026
Q1
$6.63K Sell
128
-103
-45% -$7.47K ﹤0.01% 7072
2025
Q4
$20.2K Buy
231
+130
+129% +$30.6K ﹤0.01% 6691
2025
Q3
$43K Buy
+101
New +$35.6K ﹤0.01% 6457

Other funds holding PMI

Morgan Stanley's PMI Position: Q2 2026 in Review

Morgan Stanley reduced its Picard Medical (PMI) stake by 74% in Q2 2026, selling an estimated $2.02K and leaving 33 shares worth $271. The position accounts for ﹤0.01% of the portfolio, ranked #7800.

Morgan Stanley first reported a position in PMI in Q3 2025 and has held it in 4 quarters since. The position peaked at $43K in Q3 2025. 41 funds tracked by Wall St. Rank hold PMI as of Q2 2026.

  • Morgan Stanley held 33 shares of Picard Medical worth $271 as of Q2 2026.
  • Morgan Stanley sold 95 Picard Medical shares in Q2 2026, an estimated $2.02K.
  • Picard Medical made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #7800 holding.
  • Morgan Stanley first reported a position in Picard Medical in Q3 2025 and has held it in 4 quarters since.
  • Morgan Stanley's Picard Medical position peaked at $43K in Q3 2025.
  • 41 funds tracked by Wall St. Rank held Picard Medical as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.